Cosmetic cross-reference Noindex: medium evidence

Glycogen

CAS 9005-79-2

Glycogen (CAS 9005-79-2) is a pharmaceutical compound with 0 bioactivity targets and 2 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

0

SOURCE DrugCentral

Adverse signals

2

SOURCE IUPHAR/BPS

PubMed IDs

0

SOURCE EPA DSSTox

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Glycogen

CAS Number

9005-79-2

Source Match

EPA DSSTox

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE DSSTox identifiers DTXSID3093812

Cross-Reference to Chemicals

Same-CAS substance identity is available in the industrial chemicals vertical.

Glycogen is linked to DTXSID3093812 in DSSTox identifiers.

View industrial chemical data →

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Glycogen used for in pharmaceutical contexts?

Glycogen (CAS 9005-79-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Glycogen?

Glycogen has 2 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Flushing, Speech disorder. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Glycogen also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Glycogen with EU status "permitted".

What clinical phase is Glycogen in?

No phase 1-4 clinical development badge is rendered for Glycogen because the matched compound identifier rows do not contain a max-phase value.